search
Back to results

Pupillary Dilation Reflex Assessment for Intraoperative Analgesic Titration. (PUP-AIT)

Primary Purpose

Pain, Acute, Anesthesia

Status
Completed
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
Pupillary dilation reflex
Standard of care
Sponsored by
University Hospital, Antwerp
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pain, Acute focused on measuring pupillary reflex, nociception, heart rate, intraoperative monitoring

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • > 18 jaar
  • Elective abdominal or gynaecological operation
  • ASA (American Society of Anesthesiologists classification): I - II - III

Exclusion Criteria:

  • History of invasive ophthalmological surgery
  • Known bilateral eye disease
  • Known optical of oculomotor nerve deficit
  • Active psychiatrical disease
  • Proven active pheochromocytoma
  • Opioid usage > 7 days preoperative
  • Ongoing oncological treatment with chemotherapeutic agents
  • Usage of A-1 adrenergic of beta-blocking agents
  • Preoperative usage of benzodiazepines
  • Topical atropine or phenylephrine (eye droplets)
  • Planned perioperative usage of dopamine antagonists

Sites / Locations

  • University hospital Antwerp

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Active Comparator

Experimental

Active Comparator

Arm Label

Intervention 1

Intervention 2

Intervention 3

Intervention 4

Arm Description

Pupillary dilation reflex based perioperative intravenous remifentanil administration. Starting dose 5 ng/ml by continous infusion, dosage adjustments are made after pupillary dilation reflex assessment every 10 minutes. When PPI score is 1, the dosage is decreased with 0.2 ng/ml. When PPI score is greater than 1, the dosage is increased with 0.2 ng/ml.

Anesthesiologist based perioperative intravenous remifentanil administration (daily practice, standard of care). Starting dose 5 ng/ml, dosage adjustments are made when deemed necessary by attending anesthesiologist.

Pupillary dilation reflex based perioperative intravenous sufentanil administration. Starting dose 0.1 mcg/kg bolus, dosage adjustments are made after pupillary dilation reflex assessment every 10 minutes. When PPI score is 1, no supplementary administration is executed. When PPI score is greater than 1, a supplementary bolus of 0.1 mcg/kg is given.

Anesthesiologist based perioperative intravenous sufentanil administration (daily practice, standard of care). Starting dose 0.1 mcg/kg bolus, dosage adjustments are made when deemed necessary by attending anesthesiologist.

Outcomes

Primary Outcome Measures

Postoperative pain
Numeric rating scale (NRS) pain assessment
Postoperative analgesia
Analgetic consumption

Secondary Outcome Measures

Stimulation intensity to elicit PDR
Necessary stimulation intensity generated by the pupillometer to elicit a PDR
Baseline pupil diameter
Pupil size before stimulation
Pupillary dilation reflex amplitude
The amplitude of the pupil enlargement after nociceptive stimulation
Pupillary pain index (PPI)
Generated PPI score by the pupillometer in accordance to given stimulation and pupillary dilation reflex amplitude
Opioid usage during surgery
Total dose remifentanil or sufentanil administrated during surgery, in microgram
Extubation time
The time between stop of propofol administration and patient extubation, in minutes
Postoperative nausea and vomiting
Frequency of nausea or vomiting after surgery, in numbers of events
Length of stay at the postanesthesia care unit
Hours of admission at the postanesthesia care unit after surgery until discharge to the nursing ward, in minutes
Length of hospital stay
Length of hospital stay, in days
Postoperative health status
Assessed by 5-level EQ-5D version (EQ-5D-5L), quality of life and health status questionnaire

Full Information

First Posted
August 1, 2017
Last Updated
May 12, 2023
Sponsor
University Hospital, Antwerp
Collaborators
Universiteit Antwerpen
search

1. Study Identification

Unique Protocol Identification Number
NCT03248908
Brief Title
Pupillary Dilation Reflex Assessment for Intraoperative Analgesic Titration.
Acronym
PUP-AIT
Official Title
Pupillary Dilation Reflex Assessment for Intraoperative Analgesic Titration [PUP-AIT]. A Double Blinded Randomized Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Completed
Study Start Date
October 12, 2017 (Actual)
Primary Completion Date
September 6, 2021 (Actual)
Study Completion Date
January 31, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital, Antwerp
Collaborators
Universiteit Antwerpen

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
In this double blinded randomized controlled study, the pupillary dilation reflex is used for as a nociceptive indicator for opioid administration during elective surgery under general anesthesia.
Detailed Description
An infrared camera of the video pupillometer measures the pupillary dilation reflex (PDR) in response of a nociceptive stimulus. This autonomic reflex, parasympathetic mediated in sedated patients, can be generated by various pain stimuli (built in standardized protocol, surgical incision, …) The PDR is a robust reflex, even in patients under general anesthesia, and provides a potential evaluation of the autonomous circuit within the nociceptive evaluation based on pupil dilation upon A-delta and C fibers in both electrical or mechanic stimulation. This double blind randomized controlled trial involving American Society of Anesthesiologists (ASA) classification I-III patients undergoing elective surgery under general anesthesia are recruited. Enrolled patients are randomized in four groups: (1) remifentanil administration depending on PDR results, (2) remifentanil administration depending on decision attending anesthesiologist, (3) sufentanil administration depending on PDR results, (4) sufentanil administration depending on decision attending anesthesiologist.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Acute, Anesthesia
Keywords
pupillary reflex, nociception, heart rate, intraoperative monitoring

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Double blinded randomized controlled trial
Masking
ParticipantCare ProviderOutcomes Assessor
Masking Description
The patient, the performer of the pupillary reflex measurement, and the postoperative health care provider are masked for the study arms.
Allocation
Randomized
Enrollment
120 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention 1
Arm Type
Experimental
Arm Description
Pupillary dilation reflex based perioperative intravenous remifentanil administration. Starting dose 5 ng/ml by continous infusion, dosage adjustments are made after pupillary dilation reflex assessment every 10 minutes. When PPI score is 1, the dosage is decreased with 0.2 ng/ml. When PPI score is greater than 1, the dosage is increased with 0.2 ng/ml.
Arm Title
Intervention 2
Arm Type
Active Comparator
Arm Description
Anesthesiologist based perioperative intravenous remifentanil administration (daily practice, standard of care). Starting dose 5 ng/ml, dosage adjustments are made when deemed necessary by attending anesthesiologist.
Arm Title
Intervention 3
Arm Type
Experimental
Arm Description
Pupillary dilation reflex based perioperative intravenous sufentanil administration. Starting dose 0.1 mcg/kg bolus, dosage adjustments are made after pupillary dilation reflex assessment every 10 minutes. When PPI score is 1, no supplementary administration is executed. When PPI score is greater than 1, a supplementary bolus of 0.1 mcg/kg is given.
Arm Title
Intervention 4
Arm Type
Active Comparator
Arm Description
Anesthesiologist based perioperative intravenous sufentanil administration (daily practice, standard of care). Starting dose 0.1 mcg/kg bolus, dosage adjustments are made when deemed necessary by attending anesthesiologist.
Intervention Type
Diagnostic Test
Intervention Name(s)
Pupillary dilation reflex
Intervention Description
Perioperative pupillary dilation reflex assessment is executed every 10 minutes from start sedation until extubation in patients allocated to study arm Intervention 1 and Intervention 3
Intervention Type
Other
Intervention Name(s)
Standard of care
Intervention Description
Perioperative opioid administration based on the attending anesthesiologist decision (mainly including assessment of heart rate, blood pressure, and limb movement)
Primary Outcome Measure Information:
Title
Postoperative pain
Description
Numeric rating scale (NRS) pain assessment
Time Frame
From patient extubation until postoperative day 5
Title
Postoperative analgesia
Description
Analgetic consumption
Time Frame
From patient extubation until postoperative day 5
Secondary Outcome Measure Information:
Title
Stimulation intensity to elicit PDR
Description
Necessary stimulation intensity generated by the pupillometer to elicit a PDR
Time Frame
From the day of surgery at the start of general anesthesia, assessed every 10 minutes until the end of surgery or extubation, whichever came first, assessed up to 4 hours
Title
Baseline pupil diameter
Description
Pupil size before stimulation
Time Frame
From the day of surgery at the start of general anesthesia, assessed every 10 minutes until the end of surgery or extubation, whichever came first, assessed up to 4 hours
Title
Pupillary dilation reflex amplitude
Description
The amplitude of the pupil enlargement after nociceptive stimulation
Time Frame
From the day of surgery at the start of general anesthesia, assessed every 10 minutes until the end of surgery or extubation, whichever came first, assessed up to 4 hours
Title
Pupillary pain index (PPI)
Description
Generated PPI score by the pupillometer in accordance to given stimulation and pupillary dilation reflex amplitude
Time Frame
From the day of surgery at the start of general anesthesia, assessed every 10 minutes until the end of surgery or extubation, whichever came first, assessed up to 4 hours
Title
Opioid usage during surgery
Description
Total dose remifentanil or sufentanil administrated during surgery, in microgram
Time Frame
From the day of surgery at the start of general anesthesia, assessed every 10 minutes until the end of surgery or extubation, whichever came first, assessed up to 4 hours
Title
Extubation time
Description
The time between stop of propofol administration and patient extubation, in minutes
Time Frame
From the day of surgery at the termination of propofol infusion until patient extubation, assessed up to 2 hours
Title
Postoperative nausea and vomiting
Description
Frequency of nausea or vomiting after surgery, in numbers of events
Time Frame
From patient extubation until postoperative day 5
Title
Length of stay at the postanesthesia care unit
Description
Hours of admission at the postanesthesia care unit after surgery until discharge to the nursing ward, in minutes
Time Frame
From admission at the postanesthesia care unit until discharge to the nursing ward, assessed up to 24 hours
Title
Length of hospital stay
Description
Length of hospital stay, in days
Time Frame
From the day of the planned surgery until hospital discharge, assessed up to 5 days
Title
Postoperative health status
Description
Assessed by 5-level EQ-5D version (EQ-5D-5L), quality of life and health status questionnaire
Time Frame
From extubation until 1 month after surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: > 18 jaar Elective abdominal or gynaecological operation ASA (American Society of Anesthesiologists classification): I - II - III Exclusion Criteria: History of invasive ophthalmological surgery Known bilateral eye disease Known optical of oculomotor nerve deficit Active psychiatrical disease Proven active pheochromocytoma Opioid usage > 7 days preoperative Ongoing oncological treatment with chemotherapeutic agents Usage of A-1 adrenergic of beta-blocking agents Preoperative usage of benzodiazepines Topical atropine or phenylephrine (eye droplets) Planned perioperative usage of dopamine antagonists
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Davina Wildemeersch, MD
Organizational Affiliation
University Hospital, Antwerp
Official's Role
Principal Investigator
Facility Information:
Facility Name
University hospital Antwerp
City
Edegem
State/Province
Antwerp
ZIP/Postal Code
2650
Country
Belgium

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
36189668
Citation
Vlaenderen DV, Hans G, Saldien V, Wildemeersch D. Pupillary reflex dilation and pain index evaluation during general anesthesia using sufentanil: a double-blind randomized controlled trial. Pain Manag. 2022 Nov;12(8):931-941. doi: 10.2217/pmt-2022-0027. Epub 2022 Oct 3.
Results Reference
derived

Learn more about this trial

Pupillary Dilation Reflex Assessment for Intraoperative Analgesic Titration.

We'll reach out to this number within 24 hrs